+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein



Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein



Acta Neuropathologica Communications 3: 75



Parkinson's disease (PD) and multiple system atrophy (MSA) are neurodegenerative diseases that are characterized by the intracellular accumulation of alpha-synuclein containing aggregates. Recent increasing evidence suggests that Parkinson's disease and MSA pathology spread throughout the nervous system in a spatiotemporal fashion, possibly by prion-like propagation of alpha-synuclein positive aggregates between synaptically connected areas. Concurrently, intracerebral injection of pathological alpha-synuclein into transgenic mice overexpressing human wild-type alpha-synuclein, or human alpha-synuclein with the familial A53T mutation, or into wild-type mice causes spreading of alpha-synuclein pathology in the CNS. Considering that wild-type mice naturally also express a threonine at codon 53 of alpha-synuclein, it has remained unclear whether human wild-type alpha-synuclein alone, in the absence of endogenously expressed mouse alpha-synuclein, would support a similar propagation of alpha-synuclein pathology in vivo. Here we show that brain extracts from two patients with MSA and two patients with probable incidental Lewy body disease (iLBD) but not phosphate-buffered saline induce prion-like spreading of pathological alpha-synuclein after intrastriatal injection into mice expressing human wild-type alpha-synuclein. Mice were sacrificed at 3, 6, and 9 months post injection and analyzed neuropathologically and biochemically. Mice injected with brain extracts from patients with MSA or probable iLBD both accumulated intraneuronal inclusion bodies, which stained positive for phosphorylated alpha-synuclein and appeared predominantly within the injected brain hemisphere after 6 months. After 9 months these intraneuronal inclusion bodies had spread to the contralateral hemisphere and more rostral and caudal areas. Biochemical analysis showed that brains of mice injected with brain extracts from patients with MSA and probable iLBD contained hyperphosphorylated alpha-synuclein that also seeded aggregation of recombinant human wild-type alpha-synuclein in a Thioflavin T binding assay. Our results indicate that human wild-type alpha-synuclein supports the prion-like spreading of alpha-synuclein pathology in the absence of endogenously expressed mouse alpha-synuclein in vivo.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058627008

Download citation: RISBibTeXText

PMID: 26612754

DOI: 10.1186/s40478-015-0254-7


Related references

Early and persistent motor abnormalities in transgenic mice expressing wild type human alpha - synuclein and mice lacking alpha - synuclein. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 204 20, 2003

Distinct mechanisms of axonal globule formation in mice expressing human wild type alpha-synuclein or dementia with Lewy bodies-linked P123H Ss-synuclein. 2012

Effect of combined exposure to paraquat and maneb in transgenic mice expressing human wild-type or doubly mutated alpha-synuclein Gene-environment interaction in Parkinsons disease. Society for Neuroscience Abstracts 27(1): 863, 2001

HUMAN alpha - SYNUCLEIN HARBORING ALA53THR MUTATION CAUSES NEURODENERATIVE DISEASE WITH alpha - SYNUCLEIN AGGREGATION IN TRANSGENIC MICE. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 118 10, 2002

Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein. Journal of Neuroscience Research 85(8): 1819-1825, 2007

High - resolution large - scale - D mapping studies of alpha - synuclein immunoreactivity in transgenic mice overexpressing human alpha - synuclein. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 297 10, 2003

Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice. Acta Neuropathologica 120(2): 145-154, 2010

Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology. Brain Research 1250: 232-241, 2009

Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Experimental Neurology 175(1): 35-48, 2002

Physiologic and pathologic effects of wild-type and mutated human alpha-synuclein in transgenic mice. Society for Neuroscience Abstracts 27(1): 256, 2001

Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice. Frontiers in Molecular Neuroscience 11: 321, 2018

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. Journal of Neuroscience 20(17): 6365-6373, 2000

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 99(13): 8968-8973, 2002

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 fwdarw Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 99(13): 8968-8973, June 25, 2002

Altered dopamine terminals and enhanced vulnerability to MPTP in wild-type and mutated human alpha-synuclein transgenic mice. Society for Neuroscience Abstracts 26(1-2): Abstract No -572 10, 2000